GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » AprilBio Co Ltd (XKRX:397030) » Definitions » Research & Development

AprilBio Co (XKRX:397030) Research & Development : ₩2,902 Mil (TTM As of Mar. 2025)


View and export this data going back to 2022. Start your Free Trial

What is AprilBio Co Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. AprilBio Co's Research & Development for the three months ended in Mar. 2025 was ₩593 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2025 was ₩2,902 Mil.


AprilBio Co Research & Development Historical Data

The historical data trend for AprilBio Co's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AprilBio Co Research & Development Chart

AprilBio Co Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Research & Development
Get a 7-Day Free Trial 6,780.74 13,892.17 6,924.81 8,038.13 3,204.75

AprilBio Co Quarterly Data
Dec18 Dec19 Dec20 Mar21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 895.42 360.37 470.32 1,478.64 593.15

AprilBio Co Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩2,902 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


AprilBio Co  (XKRX:397030) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.


AprilBio Co Research & Development Related Terms

Thank you for viewing the detailed overview of AprilBio Co's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.


AprilBio Co Business Description

Traded in Other Exchanges
N/A
Address
1 Kangwon National University Road, B-602, College of Medical and Life Sciences, Kangwon National University, Gangwon Special Self-Governing Province, Chuncheon-si, KOR
AprilBio Co Ltd is a bio company is developing biologis. It owns long acting protein medicine platform technology utilizing human FAB antobody parts that makes unusual combination to serum akbumin and EX 12 helper phase antibody library technology.

AprilBio Co Headlines

No Headlines